4.6 Article

Worse Outcome in Stroke Patients Treated with rt-PA Without Early Reperfusion: Associated Factors

Journal

TRANSLATIONAL STROKE RESEARCH
Volume 9, Issue 4, Pages 347-355

Publisher

SPRINGER
DOI: 10.1007/s12975-017-0584-9

Keywords

Blood-brain barrier; Critical care; Hemorrhage transformation; Ischemic stroke; Prognosis

Funding

  1. Spanish Ministry of Economy and Competitiveness [SAF2014-56336-R]
  2. Xunta de Galicia (Conselleria de Educacion) [GRC2014/027]
  3. Xunta de Galicia (Axencia Galega de Innovacion)
  4. Instituto de Salud Carlos III [PI13/00292, PI14/01879]
  5. Spanish Research Network on Cerebrovascular Diseases RETICS-INVICTUS [RD16/0019]
  6. European Union FEDER program
  7. Miguel Servet Program of Instituto de Salud Carlos III [CP12/03121, CP14/00154]
  8. FPI fellowship Spanish Ministry of Economy and Competitiveness [BES-2015-073933]

Ask authors/readers for more resources

Based on preclinical studies suggesting that recombinant tissue plasminogen activator (rt-PA) may promote ischemic brain injuries, we investigated in patients the possible risk of worse clinical outcome after rt-PA treatment as a result of its inability to resolve cerebral ischemia. Here, we designed a cohort study using a retrospective analysis of patients who received treatment with intravenous (4.5-h window) or intraarterial rt-PA, without or with thrombectomy. Controls were consecutive patients who did not receive recanalization treatment, who met all inclusion criteria. As a marker of reperfusion, we defined the variable of early neurological improvement as the difference between the score of the National Institute of Health Stroke Scale (NIHSS) (at admission and 24 h). The main variable was worsening of the patient's functional situation in the first 3 months. To compare quantitative variables, we used Student's t test or the Mann-Whitney test. To estimate the odds ratios of each independent variable in the patient's worsening in the first 3 months, we used a logistic regression model. We included 1154 patients; 577 received rt-PA, and 577 served as controls. In the group of patients treated with rt-PA, 39.4% who did not present clinical reperfusion data developed worsening within 3 months after stroke compared with 3.5% of patients with reperfusion (P < 0.0001). These differences were not significant in the control group. In summary, administration of rt-PA intravenously or intraarterially without reperfusion within the first 24 h may be associated with a higher risk of functional deterioration in the first 3 months.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available